A randomized double-blind controlled trial found post-exposure prophylaxis with hydroxychloroquine (HCQ) was not advantageous for the prevention of COVID-19 in asymptomatic individuals with high risk for SARS-CoV-2 infection. The incidence of COVID-19 was similar in both the HCQ group and control. nature.com Submitted by glawgii t3_105wwo9 on January 7, 2023 at 7:10 PM in science 184 comments 1,120
skatterbrainz t1_j3gr83g wrote on January 8, 2023 at 1:29 PM Eventually AI and machines are going to replace pharmacists. The revenue advantages for pharma shareholders will outweigh any pushback. Permalink 0
Viewing a single comment thread. View all comments